Publication & Citation Trends
Publications
0 total
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy
Cited by 2
Semantic Scholar
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART).
Cited by 1
Semantic Scholar
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy
Cited by 0
Semantic Scholar
The effect of statin use on survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted therapies (ART).
Cited by 0
Semantic Scholar
Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART).
Cited by 0
Semantic Scholar
Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy.
Cited by 0
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(12)
Prostate Cancer Treatment and Research
(8)
Animal Virus Infections Studies
(6)
Virology and Viral Diseases
(5)
Cancer, Lipids, and Metabolism
(4)
Affiliations
Icahn School of Medicine at Mount Sinai